1 Study Coverage
    1.1 Metoclopramide Product Introduction
    1.2 Market by Type
        1.2.1 Global Metoclopramide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Oral
        1.2.3 Injection
    1.3 Market by Application
        1.3.1 Global Metoclopramide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Nausea
        1.3.3 Migraine
        1.3.4 Gastroparesis
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Metoclopramide Sales Estimates and Forecasts 2017-2028
    2.2 Global Metoclopramide Revenue Estimates and Forecasts 2017-2028
    2.3 Global Metoclopramide Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Metoclopramide Sales by Region
        2.4.1 Global Metoclopramide Sales by Region (2017-2022)
        2.4.2 Global Sales Metoclopramide by Region (2023-2028)
    2.5 Global Metoclopramide Revenue by Region
        2.5.1 Global Metoclopramide Revenue by Region (2017-2022)
        2.5.2 Global Metoclopramide Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Metoclopramide Sales by Manufacturers
        3.1.1 Global Top Metoclopramide Manufacturers by Sales (2017-2022)
        3.1.2 Global Metoclopramide Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Metoclopramide in 2021
    3.2 Global Metoclopramide Revenue by Manufacturers
        3.2.1 Global Metoclopramide Revenue by Manufacturers (2017-2022)
        3.2.2 Global Metoclopramide Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Metoclopramide Revenue in 2021
    3.3 Global Metoclopramide Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Metoclopramide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Metoclopramide Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Metoclopramide Sales by Type
        4.1.1 Global Metoclopramide Historical Sales by Type (2017-2022)
        4.1.2 Global Metoclopramide Forecasted Sales by Type (2023-2028)
        4.1.3 Global Metoclopramide Sales Market Share by Type (2017-2028)
    4.2 Global Metoclopramide Revenue by Type
        4.2.1 Global Metoclopramide Historical Revenue by Type (2017-2022)
        4.2.2 Global Metoclopramide Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Metoclopramide Revenue Market Share by Type (2017-2028)
    4.3 Global Metoclopramide Price by Type
        4.3.1 Global Metoclopramide Price by Type (2017-2022)
        4.3.2 Global Metoclopramide Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Metoclopramide Sales by Application
        5.1.1 Global Metoclopramide Historical Sales by Application (2017-2022)
        5.1.2 Global Metoclopramide Forecasted Sales by Application (2023-2028)
        5.1.3 Global Metoclopramide Sales Market Share by Application (2017-2028)
    5.2 Global Metoclopramide Revenue by Application
        5.2.1 Global Metoclopramide Historical Revenue by Application (2017-2022)
        5.2.2 Global Metoclopramide Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Metoclopramide Revenue Market Share by Application (2017-2028)
    5.3 Global Metoclopramide Price by Application
        5.3.1 Global Metoclopramide Price by Application (2017-2022)
        5.3.2 Global Metoclopramide Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Metoclopramide Market Size by Type
        6.1.1 North America Metoclopramide Sales by Type (2017-2028)
        6.1.2 North America Metoclopramide Revenue by Type (2017-2028)
    6.2 North America Metoclopramide Market Size by Application
        6.2.1 North America Metoclopramide Sales by Application (2017-2028)
        6.2.2 North America Metoclopramide Revenue by Application (2017-2028)
    6.3 North America Metoclopramide Market Size by Country
        6.3.1 North America Metoclopramide Sales by Country (2017-2028)
        6.3.2 North America Metoclopramide Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Metoclopramide Market Size by Type
        7.1.1 Europe Metoclopramide Sales by Type (2017-2028)
        7.1.2 Europe Metoclopramide Revenue by Type (2017-2028)
    7.2 Europe Metoclopramide Market Size by Application
        7.2.1 Europe Metoclopramide Sales by Application (2017-2028)
        7.2.2 Europe Metoclopramide Revenue by Application (2017-2028)
    7.3 Europe Metoclopramide Market Size by Country
        7.3.1 Europe Metoclopramide Sales by Country (2017-2028)
        7.3.2 Europe Metoclopramide Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Metoclopramide Market Size by Type
        8.1.1 Asia Pacific Metoclopramide Sales by Type (2017-2028)
        8.1.2 Asia Pacific Metoclopramide Revenue by Type (2017-2028)
    8.2 Asia Pacific Metoclopramide Market Size by Application
        8.2.1 Asia Pacific Metoclopramide Sales by Application (2017-2028)
        8.2.2 Asia Pacific Metoclopramide Revenue by Application (2017-2028)
    8.3 Asia Pacific Metoclopramide Market Size by Region
        8.3.1 Asia Pacific Metoclopramide Sales by Region (2017-2028)
        8.3.2 Asia Pacific Metoclopramide Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Metoclopramide Market Size by Type
        9.1.1 Latin America Metoclopramide Sales by Type (2017-2028)
        9.1.2 Latin America Metoclopramide Revenue by Type (2017-2028)
    9.2 Latin America Metoclopramide Market Size by Application
        9.2.1 Latin America Metoclopramide Sales by Application (2017-2028)
        9.2.2 Latin America Metoclopramide Revenue by Application (2017-2028)
    9.3 Latin America Metoclopramide Market Size by Country
        9.3.1 Latin America Metoclopramide Sales by Country (2017-2028)
        9.3.2 Latin America Metoclopramide Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Metoclopramide Market Size by Type
        10.1.1 Middle East and Africa Metoclopramide Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Metoclopramide Revenue by Type (2017-2028)
    10.2 Middle East and Africa Metoclopramide Market Size by Application
        10.2.1 Middle East and Africa Metoclopramide Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Metoclopramide Revenue by Application (2017-2028)
    10.3 Middle East and Africa Metoclopramide Market Size by Country
        10.3.1 Middle East and Africa Metoclopramide Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Metoclopramide Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Teva
        11.1.1 Teva Corporation Information
        11.1.2 Teva Overview
        11.1.3 Teva Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Teva Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Teva Recent Developments
    11.2 Sanofi
        11.2.1 Sanofi Corporation Information
        11.2.2 Sanofi Overview
        11.2.3 Sanofi Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Sanofi Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Sanofi Recent Developments
    11.3 Astellas
        11.3.1 Astellas Corporation Information
        11.3.2 Astellas Overview
        11.3.3 Astellas Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Astellas Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Astellas Recent Developments
    11.4 Adwya
        11.4.1 Adwya Corporation Information
        11.4.2 Adwya Overview
        11.4.3 Adwya Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Adwya Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Adwya Recent Developments
    11.5 Biofarma
        11.5.1 Biofarma Corporation Information
        11.5.2 Biofarma Overview
        11.5.3 Biofarma Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Biofarma Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Biofarma Recent Developments
    11.6 Apotex
        11.6.1 Apotex Corporation Information
        11.6.2 Apotex Overview
        11.6.3 Apotex Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Apotex Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Apotex Recent Developments
    11.7 Novartis
        11.7.1 Novartis Corporation Information
        11.7.2 Novartis Overview
        11.7.3 Novartis Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Novartis Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Novartis Recent Developments
    11.8 ASKA Seiyaku Asuka
        11.8.1 ASKA Seiyaku Asuka Corporation Information
        11.8.2 ASKA Seiyaku Asuka Overview
        11.8.3 ASKA Seiyaku Asuka Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 ASKA Seiyaku Asuka Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 ASKA Seiyaku Asuka Recent Developments
    11.9 Yang Sheng
        11.9.1 Yang Sheng Corporation Information
        11.9.2 Yang Sheng Overview
        11.9.3 Yang Sheng Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Yang Sheng Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Yang Sheng Recent Developments
    11.10 Meda Pharma
        11.10.1 Meda Pharma Corporation Information
        11.10.2 Meda Pharma Overview
        11.10.3 Meda Pharma Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Meda Pharma Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Meda Pharma Recent Developments
    11.11 Johnson and Johnson
        11.11.1 Johnson and Johnson Corporation Information
        11.11.2 Johnson and Johnson Overview
        11.11.3 Johnson and Johnson Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Johnson and Johnson Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Johnson and Johnson Recent Developments
    11.12 GSK
        11.12.1 GSK Corporation Information
        11.12.2 GSK Overview
        11.12.3 GSK Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 GSK Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 GSK Recent Developments
    11.13 Alkaloid Pharmaceuticals
        11.13.1 Alkaloid Pharmaceuticals Corporation Information
        11.13.2 Alkaloid Pharmaceuticals Overview
        11.13.3 Alkaloid Pharmaceuticals Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Alkaloid Pharmaceuticals Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Alkaloid Pharmaceuticals Recent Developments
    11.14 Teuto Brasileiro
        11.14.1 Teuto Brasileiro Corporation Information
        11.14.2 Teuto Brasileiro Overview
        11.14.3 Teuto Brasileiro Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Teuto Brasileiro Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Teuto Brasileiro Recent Developments
    11.15 Mylan
        11.15.1 Mylan Corporation Information
        11.15.2 Mylan Overview
        11.15.3 Mylan Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Mylan Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Mylan Recent Developments
    11.16 EU-Pharma
        11.16.1 EU-Pharma Corporation Information
        11.16.2 EU-Pharma Overview
        11.16.3 EU-Pharma Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 EU-Pharma Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 EU-Pharma Recent Developments
    11.17 Le Vet
        11.17.1 Le Vet Corporation Information
        11.17.2 Le Vet Overview
        11.17.3 Le Vet Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 Le Vet Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Le Vet Recent Developments
    11.18 Omega Laboratories
        11.18.1 Omega Laboratories Corporation Information
        11.18.2 Omega Laboratories Overview
        11.18.3 Omega Laboratories Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.18.4 Omega Laboratories Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.18.5 Omega Laboratories Recent Developments
    11.19 Orion Pharma
        11.19.1 Orion Pharma Corporation Information
        11.19.2 Orion Pharma Overview
        11.19.3 Orion Pharma Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.19.4 Orion Pharma Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.19.5 Orion Pharma Recent Developments
    11.20 Pfizer
        11.20.1 Pfizer Corporation Information
        11.20.2 Pfizer Overview
        11.20.3 Pfizer Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.20.4 Pfizer Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.20.5 Pfizer Recent Developments
    11.21 Wockhardt
        11.21.1 Wockhardt Corporation Information
        11.21.2 Wockhardt Overview
        11.21.3 Wockhardt Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.21.4 Wockhardt Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.21.5 Wockhardt Recent Developments
    11.22 Amneal Pharmaceuticals
        11.22.1 Amneal Pharmaceuticals Corporation Information
        11.22.2 Amneal Pharmaceuticals Overview
        11.22.3 Amneal Pharmaceuticals Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.22.4 Amneal Pharmaceuticals Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.22.5 Amneal Pharmaceuticals Recent Developments
    11.23 Nidda
        11.23.1 Nidda Corporation Information
        11.23.2 Nidda Overview
        11.23.3 Nidda Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.23.4 Nidda Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.23.5 Nidda Recent Developments
    11.24 Ceva Sante Animale
        11.24.1 Ceva Sante Animale Corporation Information
        11.24.2 Ceva Sante Animale Overview
        11.24.3 Ceva Sante Animale Metoclopramide Sales, Price, Revenue and Gross Margin (2017-2022)
        11.24.4 Ceva Sante Animale Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
        11.24.5 Ceva Sante Animale Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Metoclopramide Industry Chain Analysis
    12.2 Metoclopramide Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Metoclopramide Production Mode & Process
    12.4 Metoclopramide Sales and Marketing
        12.4.1 Metoclopramide Sales Channels
        12.4.2 Metoclopramide Distributors
    12.5 Metoclopramide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Metoclopramide Industry Trends
    13.2 Metoclopramide Market Drivers
    13.3 Metoclopramide Market Challenges
    13.4 Metoclopramide Market Restraints
14 Key Findings in The Global Metoclopramide Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Metoclopramide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Oral
    Table 3. Major Manufacturers of Injection
    Table 4. Global Metoclopramide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Metoclopramide Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Metoclopramide Sales by Region (2017-2022) & (K Units)
    Table 7. Global Metoclopramide Sales Market Share by Region (2017-2022)
    Table 8. Global Metoclopramide Sales by Region (2023-2028) & (K Units)
    Table 9. Global Metoclopramide Sales Market Share by Region (2023-2028)
    Table 10. Global Metoclopramide Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Metoclopramide Revenue Market Share by Region (2017-2022)
    Table 12. Global Metoclopramide Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Metoclopramide Revenue Market Share by Region (2023-2028)
    Table 14. Global Metoclopramide Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Metoclopramide Sales Share by Manufacturers (2017-2022)
    Table 16. Global Metoclopramide Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Metoclopramide Revenue Share by Manufacturers (2017-2022)
    Table 18. Metoclopramide Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Metoclopramide Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Metoclopramide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metoclopramide as of 2021)
    Table 21. Metoclopramide Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Metoclopramide Product Offered
    Table 23. Date of Manufacturers Enter into Metoclopramide Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Metoclopramide Sales by Type (2017-2022) & (K Units)
    Table 26. Global Metoclopramide Sales by Type (2023-2028) & (K Units)
    Table 27. Global Metoclopramide Sales Share by Type (2017-2022)
    Table 28. Global Metoclopramide Sales Share by Type (2023-2028)
    Table 29. Global Metoclopramide Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Metoclopramide Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Metoclopramide Revenue Share by Type (2017-2022)
    Table 32. Global Metoclopramide Revenue Share by Type (2023-2028)
    Table 33. Metoclopramide Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Metoclopramide Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Metoclopramide Sales by Application (2017-2022) & (K Units)
    Table 36. Global Metoclopramide Sales by Application (2023-2028) & (K Units)
    Table 37. Global Metoclopramide Sales Share by Application (2017-2022)
    Table 38. Global Metoclopramide Sales Share by Application (2023-2028)
    Table 39. Global Metoclopramide Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Metoclopramide Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Metoclopramide Revenue Share by Application (2017-2022)
    Table 42. Global Metoclopramide Revenue Share by Application (2023-2028)
    Table 43. Metoclopramide Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Metoclopramide Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Metoclopramide Sales by Type (2017-2022) & (K Units)
    Table 46. North America Metoclopramide Sales by Type (2023-2028) & (K Units)
    Table 47. North America Metoclopramide Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Metoclopramide Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Metoclopramide Sales by Application (2017-2022) & (K Units)
    Table 50. North America Metoclopramide Sales by Application (2023-2028) & (K Units)
    Table 51. North America Metoclopramide Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Metoclopramide Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Metoclopramide Sales by Country (2017-2022) & (K Units)
    Table 54. North America Metoclopramide Sales by Country (2023-2028) & (K Units)
    Table 55. North America Metoclopramide Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Metoclopramide Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Metoclopramide Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Metoclopramide Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Metoclopramide Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Metoclopramide Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Metoclopramide Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Metoclopramide Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Metoclopramide Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Metoclopramide Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Metoclopramide Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Metoclopramide Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Metoclopramide Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Metoclopramide Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Metoclopramide Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Metoclopramide Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Metoclopramide Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Metoclopramide Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Metoclopramide Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Metoclopramide Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Metoclopramide Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Metoclopramide Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Metoclopramide Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Metoclopramide Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Metoclopramide Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Metoclopramide Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Metoclopramide Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Metoclopramide Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Metoclopramide Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Metoclopramide Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Metoclopramide Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Metoclopramide Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Metoclopramide Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Metoclopramide Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Metoclopramide Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Metoclopramide Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Metoclopramide Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Metoclopramide Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Metoclopramide Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Metoclopramide Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Metoclopramide Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Metoclopramide Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Metoclopramide Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Metoclopramide Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Metoclopramide Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Metoclopramide Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Metoclopramide Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Metoclopramide Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Metoclopramide Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Metoclopramide Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Teva Corporation Information
    Table 106. Teva Description and Major Businesses
    Table 107. Teva Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. Teva Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Teva Recent Developments
    Table 110. Sanofi Corporation Information
    Table 111. Sanofi Description and Major Businesses
    Table 112. Sanofi Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. Sanofi Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Sanofi Recent Developments
    Table 115. Astellas Corporation Information
    Table 116. Astellas Description and Major Businesses
    Table 117. Astellas Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. Astellas Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Astellas Recent Developments
    Table 120. Adwya Corporation Information
    Table 121. Adwya Description and Major Businesses
    Table 122. Adwya Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Adwya Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Adwya Recent Developments
    Table 125. Biofarma Corporation Information
    Table 126. Biofarma Description and Major Businesses
    Table 127. Biofarma Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. Biofarma Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Biofarma Recent Developments
    Table 130. Apotex Corporation Information
    Table 131. Apotex Description and Major Businesses
    Table 132. Apotex Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Apotex Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Apotex Recent Developments
    Table 135. Novartis Corporation Information
    Table 136. Novartis Description and Major Businesses
    Table 137. Novartis Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. Novartis Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Novartis Recent Developments
    Table 140. ASKA Seiyaku Asuka Corporation Information
    Table 141. ASKA Seiyaku Asuka Description and Major Businesses
    Table 142. ASKA Seiyaku Asuka Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 143. ASKA Seiyaku Asuka Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. ASKA Seiyaku Asuka Recent Developments
    Table 145. Yang Sheng Corporation Information
    Table 146. Yang Sheng Description and Major Businesses
    Table 147. Yang Sheng Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 148. Yang Sheng Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Yang Sheng Recent Developments
    Table 150. Meda Pharma Corporation Information
    Table 151. Meda Pharma Description and Major Businesses
    Table 152. Meda Pharma Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 153. Meda Pharma Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Meda Pharma Recent Developments
    Table 155. Johnson and Johnson Corporation Information
    Table 156. Johnson and Johnson Description and Major Businesses
    Table 157. Johnson and Johnson Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 158. Johnson and Johnson Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Johnson and Johnson Recent Developments
    Table 160. GSK Corporation Information
    Table 161. GSK Description and Major Businesses
    Table 162. GSK Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 163. GSK Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. GSK Recent Developments
    Table 165. Alkaloid Pharmaceuticals Corporation Information
    Table 166. Alkaloid Pharmaceuticals Description and Major Businesses
    Table 167. Alkaloid Pharmaceuticals Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 168. Alkaloid Pharmaceuticals Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Alkaloid Pharmaceuticals Recent Developments
    Table 170. Teuto Brasileiro Corporation Information
    Table 171. Teuto Brasileiro Description and Major Businesses
    Table 172. Teuto Brasileiro Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 173. Teuto Brasileiro Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Teuto Brasileiro Recent Developments
    Table 175. Mylan Corporation Information
    Table 176. Mylan Description and Major Businesses
    Table 177. Mylan Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 178. Mylan Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 179. Mylan Recent Developments
    Table 180. EU-Pharma Corporation Information
    Table 181. EU-Pharma Description and Major Businesses
    Table 182. EU-Pharma Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 183. EU-Pharma Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 184. EU-Pharma Recent Developments
    Table 185. Le Vet Corporation Information
    Table 186. Le Vet Description and Major Businesses
    Table 187. Le Vet Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 188. Le Vet Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 189. Le Vet Recent Developments
    Table 190. Omega Laboratories Corporation Information
    Table 191. Omega Laboratories Description and Major Businesses
    Table 192. Omega Laboratories Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 193. Omega Laboratories Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 194. Omega Laboratories Recent Developments
    Table 195. Orion Pharma Corporation Information
    Table 196. Orion Pharma Description and Major Businesses
    Table 197. Orion Pharma Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 198. Orion Pharma Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 199. Orion Pharma Recent Developments
    Table 200. Pfizer Corporation Information
    Table 201. Pfizer Description and Major Businesses
    Table 202. Pfizer Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 203. Pfizer Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 204. Pfizer Recent Developments
    Table 205. Wockhardt Corporation Information
    Table 206. Wockhardt Description and Major Businesses
    Table 207. Wockhardt Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 208. Wockhardt Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 209. Wockhardt Recent Developments
    Table 210. Amneal Pharmaceuticals Corporation Information
    Table 211. Amneal Pharmaceuticals Description and Major Businesses
    Table 212. Amneal Pharmaceuticals Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 213. Amneal Pharmaceuticals Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 214. Amneal Pharmaceuticals Recent Developments
    Table 215. Nidda Corporation Information
    Table 216. Nidda Description and Major Businesses
    Table 217. Nidda Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 218. Nidda Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 219. Nidda Recent Developments
    Table 220. Ceva Sante Animale Corporation Information
    Table 221. Ceva Sante Animale Description and Major Businesses
    Table 222. Ceva Sante Animale Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 223. Ceva Sante Animale Metoclopramide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 224. Ceva Sante Animale Recent Developments
    Table 225. Key Raw Materials Lists
    Table 226. Raw Materials Key Suppliers Lists
    Table 227. Metoclopramide Distributors List
    Table 228. Metoclopramide Customers List
    Table 229. Metoclopramide Market Trends
    Table 230. Metoclopramide Market Drivers
    Table 231. Metoclopramide Market Challenges
    Table 232. Metoclopramide Market Restraints
    Table 233. Research Programs/Design for This Report
    Table 234. Key Data Information from Secondary Sources
    Table 235. Key Data Information from Primary Sources
List of Figures
    Figure 1. Metoclopramide Product Picture
    Figure 3. Global Metoclopramide Market Share by Type in 2021 & 2028
    Figure 3. Oral Product Picture
    Figure 4. Injection Product Picture
    Figure 5. Global Metoclopramide Market Share by Application in 2021 & 2028
    Figure 6. Nausea
    Figure 7. Migraine
    Figure 8. Gastroparesis
    Figure 9. Metoclopramide Report Years Considered
    Figure 10. Global Metoclopramide Sales 2017-2028 (K Units)
    Figure 11. Global Metoclopramide Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Metoclopramide Revenue 2017-2028 (US$ Million)
    Figure 13. Global Metoclopramide Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Metoclopramide Sales Market Share by Region (2017-2022)
    Figure 15. Global Metoclopramide Sales Market Share by Region (2023-2028)
    Figure 16. North America Metoclopramide Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Metoclopramide Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Metoclopramide Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Metoclopramide Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Metoclopramide Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Metoclopramide Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Metoclopramide Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Metoclopramide Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Metoclopramide Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Metoclopramide Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Metoclopramide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Metoclopramide in the World: Market Share by Metoclopramide Revenue in 2021
    Figure 28. Global Metoclopramide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Metoclopramide Sales Market Share by Type (2017-2028)
    Figure 30. Global Metoclopramide Revenue Market Share by Type (2017-2028)
    Figure 31. Global Metoclopramide Sales Market Share by Application (2017-2028)
    Figure 32. Global Metoclopramide Revenue Market Share by Application (2017-2028)
    Figure 33. North America Metoclopramide Sales Market Share by Type (2017-2028)
    Figure 34. North America Metoclopramide Revenue Market Share by Type (2017-2028)
    Figure 35. North America Metoclopramide Sales Market Share by Application (2017-2028)
    Figure 36. North America Metoclopramide Revenue Market Share by Application (2017-2028)
    Figure 37. North America Metoclopramide Sales Share by Country (2017-2028)
    Figure 38. North America Metoclopramide Revenue Share by Country (2017-2028)
    Figure 39. United States Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Metoclopramide Sales Market Share by Type (2017-2028)
    Figure 42. Europe Metoclopramide Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Metoclopramide Sales Market Share by Application (2017-2028)
    Figure 44. Europe Metoclopramide Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Metoclopramide Sales Share by Country (2017-2028)
    Figure 46. Europe Metoclopramide Revenue Share by Country (2017-2028)
    Figure 47. Germany Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 48. France Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Metoclopramide Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Metoclopramide Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Metoclopramide Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Metoclopramide Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Metoclopramide Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Metoclopramide Revenue Share by Region (2017-2028)
    Figure 58. China Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 61. India Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Metoclopramide Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Metoclopramide Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Metoclopramide Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Metoclopramide Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Metoclopramide Sales Share by Country (2017-2028)
    Figure 72. Latin America Metoclopramide Revenue Share by Country (2017-2028)
    Figure 73. Mexico Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Metoclopramide Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Metoclopramide Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Metoclopramide Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Metoclopramide Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Metoclopramide Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Metoclopramide Revenue Share by Country (2017-2028)
    Figure 82. Turkey Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Metoclopramide Revenue (2017-2028) & (US$ Million)
    Figure 85. Metoclopramide Value Chain
    Figure 86. Metoclopramide Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed